Explained National

With the News Cycle Abuzz and Hopeful of a Vaccine’s Arrival, Here is Why India Has a Higher Stake

Oxford university vaccine for Coronavirus

The initial trial results of Oxford University’s vaccine for Coronavirus reported a success, as it has not shown any ill-effects on humans administered the vaccine. Just the other day, Covaxin by Bharat Biotech also started the human trials. Whether it is the UK-based vaccine, or that of an Indian company or a vaccine from different part of the world succeed finally, India definitely has a role to play. That is what is keeping the hope of India high, knowing that it can make available the dosage to its citizens whenever and from wherever the vaccine arrives.

Here are the reasons for India’s vaccine hope.

  • Pune-based Serum institute has an agreement with Oxford University’s Jenner Institute and AstraZeneca that are leading the vaccine race now. In fact, Adar Poonawalla of the Serum institute had claimed back in April 2020 that they will start producing vaccine doses even as the trials were on in UK.
  • Now, the head of the institute said that they are planning to start human trials in India around August 2020. Earlier, speaking on how can one expect the vaccine to arrive in quick phase, he highlighted how the present administration at the Centre ensured that the regulatory approvals to be given in a time-frame manner.
  • India’s External Affairs Minister on a global platform had recently pointed out thatirrespective of whatever part of the world the vaccine for Corona may come, only India has the capacity to make it affordable to the world with its strong pharma industry.
  • Meanwhile India, with its strong Pharma industry, has gained the trust of the world by delivering medicine during the pandemic to more than 120 countries of the world, including the smaller countries that often get ignored.
  • Now, the words of Adar Poonawalla of the Serum institute also further echo this point when he said, “they have plan to produce at one billion doses of the AstraZeneca Oxford vaccine over the next one year. The vaccines will be for India and middle- and low- income countries across the world.”
  • Back in April 2020, the Us Secretary of State Mike Pompeo had said that they are working with India on a Covid-19 vaccine, especially emphasising supply chain cooperation.
  • India’s long record of supplying vaccines for other diseases under the United Nations programme has already earned the goodwill of the world.